[Uric acid metabolism abnormalities in IgA nephropathies]

Area of Science:

• Pediatric Nephrology
• Urolithiasis Research
• Immunoglobulin A Nephropathy

Background:

• IgA nephropathy (IgAN) is a common cause of glomerulonephritis in children.
• Uric acid nephrolithiasis is a potential complication, but its association with IgAN requires further investigation.
• Hematuric glomerulopathies present diverse etiologies, necessitating differential diagnosis.

Purpose of the Study:

• To analyze the incidence of uric acid tract stones in children with IgA nephropathy compared to other hematuric glomerulopathies.
• To investigate the relationship between serum uric acid levels, urinary excretion, and stone formation in pediatric kidney diseases.
• To evaluate the efficacy of prophylactic treatment in preventing uric acid stone recurrence and disease exacerbations.

Main Methods:

• Comparative analysis of 12 children with IgA nephropathy and 10 children with other hematuric glomerulopathies.
• Measurement of serum uric acid levels and urinary uric acid excretion.
• Monitoring for uric acid nephrolithiasis and urinary tract infections.
• Assessment of prophylactic treatment including dietary modifications, fluid intake, and urinary pH management.

Main Results:

• Elevated serum uric acid and increased urinary excretion were observed in IgAN patients during disease exacerbation.
• Uric acid nephrolithiasis was exclusively diagnosed in children with IgA nephropathy.
• Prophylactic interventions significantly reduced disease exacerbations, urinary tract infections, and uric acid stone formation.

Conclusions:

• Children with IgA nephropathy are at risk for uric acid stone formation, particularly during active disease phases.
• Management strategies focusing on hydration, diet, and urinary pH are crucial for preventing complications in pediatric IgAN.
• Early detection and intervention can mitigate the burden of urolithiasis in children with IgA nephropathy.